Publications

1. Odah T, Karime C, Desai A, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib. Dig Dis Sci. 2024 Oct; 69 (10):3911-3919 Epub 2024 Sept 09
   View PubMed
2. Karime C, Black CN, Cortes P, Kwon JY, Caldera F, Crosby SK, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination. Am J Gastroenterol. 2024 Oct 1; 119 (10):2079-2085 Epub 2024 May 08
   View PubMed
3. Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA. Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study. Inflamm Bowel Dis. 2024 Jul 12 Epub 2024 July 12
   View PubMed
4. Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Sirolimus Use in Refractory Crohn's Disease. ACG Case Rep J. 2024 Jun; 11 (6):e01368 Epub 2024 June 14
   View PubMed
5. Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease. Crohns Colitis 360. 2024 Jan; 6(1):otae007. Epub 2024 Jan 24.
   View PubMed
6. Wang MH, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Monroe K, Nix BD, Newberry RD, Faubion WA. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease. BMJ Open Gastroenterol. 2023 Oct; 10 (1)
   View PubMed
7. Wang MH, Friton JJ, Rebert N, Monroe K, Nix BD, Fiocchi C, Raffals LE, Leighton JA, Pasha SF, Picco MF, Newberry RD, Achkar JP, Faubion WA. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis. Clin Transl Gastroenterol. 2023 Sep 1; 14 (9):e00615 Epub 2023 Sept 01
   View PubMed
8. Loeb L, Nasir A, Picco MF, Hashash JG, Kinnucan JA, Farraye FA. Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease. Inflamm Bowel Dis 2023 Sep 1; 29 (9):e37
   View PubMed
9. Bali AS, Hashash JG, Picco MF, Kinnucan JA, Farraye FA. Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training. Am J Gastroenterol. 2023 Jul 1; 118 (7):1282-1284 Epub 2023 Mar 20
   View PubMed
10. Karime C, Hashash JG, Picco MF, Craver EC, Murray JA, Farraye FA. The Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on the Long-term Disease Course of Patients With Crohn's Disease. J Clin Gastroenterol. 2023 Jun 26 Epub 2023 June 26
    View PubMed
11. Guerrero Vinsard D, Bruining DH, East JE, Ebner D, Kane SV, Kisiel JB, Leighton JA, Lennon RJ, Loftus EV Jr, Malik T, Picco M, Raffals L, Ramos GP, Santiago P, Coelho-Prabhu N. Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc. 2023 Apr; 97 (4):790-798.e2 Epub 2022 Nov 17
    View PubMed
12. Kwon JY, Daoud ND, Hashash JG, Picco MF, Farraye FA. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Feb 1; 29 (2):254-259
    View PubMed
13. Kroner PT, Picco MF, Cangemi JR, Hayney MS, Farraye FA, Caldera F. The Burden of Vaccine-preventable Diseases in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol. 2022 Oct 1; 56 (9):798-804 Epub 2022 Feb 14
    View PubMed
14. Daoud ND, Hashash JG, Picco MF, Farraye FA. Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease. J Crohns Colitis. 2022 May 10; 16 (4):601-605
    View PubMed
15. Kroner PT, Merchea A, Colibaseanu D, Picco MF, Farraye FA, Stocchi L. The use of ileal pouch-anal anastomosis in patients with ulcerative colitis from 2009 to 2018. Colorectal Dis. 2022 Mar; 24 (3):308-313 Epub 2021 Dec 02
    View PubMed
16. Daoud ND, Ghoz H, Cannon R, Farraye JA, Picco MF, Kane SV, Kochhar GS, Woodhams EJ, Farraye FA. Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's Disease. Crohns Colitis 360. 2022 Jan; 4 (1):otab078 Epub 2021 Nov 13
    View PubMed
17. Fluxa D, Karime C, Wang J, Brahmbhatt B, Lukens F, Stark M, Picco M, Hashash J, Farraye F. P032 Clinical Usefulness of Double Balloon Enteroscopy in Patients With Established or Suspected Small Bowel Crohn's Disease. Am J Gastroenterol. 2021 Dec 1; 116 (Suppl 1):S8
    View PubMed
18. Wang MH, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Monroe K, Nix BD, Newberry RD, Faubion WA. Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients. Inflamm Bowel Dis. 2021 Nov 15; 27 (12):1968-1974
    View PubMed
19. Robelin K, Senada P, Ghoz H, Sim L, Lebow J, Picco M, Cangemi J, Farraye FA, Werlang M. Prevalence and Clinician Recognition of Avoidant/Restrictive Food Intake Disorder in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021 Nov; 17 (11):510-514
    View PubMed
20. Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 Nov 1; 116 (11):2296-2299
    View PubMed
21. Bali AS, Picco MF, Hashash JG, Farraye FA, Kroner PT. Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018. Crohns Colitis 360. 2021 Oct; 3 (4):otab080 Epub 2021 Dec 05
    View PubMed
22. Hashash JG, Picco MF, Farraye FA. Health Maintenance for Adult Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2021; 19 (4):583-596 Epub 2021 Nov 22
    View PubMed
23. Corral JE, Hoogenboom SA, Kroner PT, Vazquez-Roque MI, Picco MF, Farraye FA, Wallace MB. COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis. Gastrointest Endosc. 2020 Sep; 92 (3):524-534.e6 Epub 2020 Apr 28
    View PubMed
24. Wang MH, Mousa OY, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Inflamm Bowel Dis. 2020 Apr 11; 26 (5):774-779
    View PubMed
25. Limdi JK, Picco M, Farraye FA. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2020 Apr; 91 (4):733-745 Epub 2019 Nov 29
    View PubMed
26. Labarca G, Drake L, Horta G, Jantz MA, Mehta HJ, Fernandez-Bussy S, Folch E, Majid A, Picco M. Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med. 2019 Oct 28; 19 (1):186
    View PubMed
27. Picco MF, Farraye FA. Targeting Mucosal Healing in Crohn's Disease. Gastroenterol Hepatol (N Y). 2019 Oct; 15 (10):529-538
    View PubMed
28. Wang , Mousa OY, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Inflamm Bowel Dis. 2019.
    
29. Wang MH, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease. J Crohns Colitis. 2019 Aug 14; 13 (8):1036-1043
    View PubMed
30. Picco MF. Is autofluorescence inferior to chromoendoscopy for dysplasia detection in ulcerative colitis? Lancet Gastroenterol Hepatol 2018 May; 3 (5):290-291 Epub 2018 Mar 20
    View PubMed
31. Wang MH, Picco MF. Crohn's Disease: Genetics Update. Gastroenterol Clin North Am. 2017 Sep; 46 (3):449-461 Epub 2017 July 19
    View PubMed
32. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Decreased Risk of Colorectal Cancer after Colonoscopy in Patients 76-85 Years Old in the United States. Digestion. 2016; 93: (2)132-8.
    View PubMed
33. Sanduleanu S, Kaltenbach T, Barkun A, McCabe RP, Velayos F, Picco MF, Laine L, Soetikno R, McQuaid KR. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016 Jan; 83: (1)213-22.
    View PubMed
34. Bartel MJ, Picco MF, Wallace MB. Chromocolonoscopy. Gastrointest Endosc Clin N Am. 2015 Apr; 25: (2)243-60.
    View PubMed
35. Picco MF. The changing approach to Colorectal cancer surveillance in Ulcerative Colitis Northeast Florida Medical Journal .2015;66:32-36.
    
36. Wallace MB, Crook JE, Coe S, Ussui V, Staggs E, Almansa C, Patel MK, Bouras E, Cangemi J, Keaveny A, Picco M, Riegert-Johnson D. Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy. Gastrointest Endosc. 2014 Dec; 80 (6):1072-87 Epub 2014 June 25
    View PubMed
37. Leong RW, Butcher RO, Picco MF. Implementation of image-enhanced endoscopy into solo and group practices for dysplasia detection in Crohn's disease and ulcerative colitis. Gastrointest Endosc Clin N Am. 2014 Jul; 24 (3):419-25
    View PubMed
38. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis. Digestion. 2014; 90(1):58-62. Epub 2014 Sep 02.
    View PubMed
39. Picco MF, Pasha S, Leighton JA, Bruining D, Loftus EV Jr, Thomas CS, Crook JE, Krishna M, Wallace M. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis. 2013 Aug; 19 (9):1913-20
    View PubMed
40. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005. Mayo Clin Proc. 2013 May; 88(5):464-70. Epub 2013 Mar 21.
    View PubMed
41. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005. Mayo Clin Proc. 2013 May; 88(5):471-8. Epub 2013 Apr 04.
    View PubMed
42. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol. 2013 Mar; 108(3):444-9. Epub 2013 Jan 08.
    View PubMed
43. Wang YR, Loftus EV Jr, Cangemi JR, Picco MF. Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013; 88 (1):20-5 Epub 2013 June 22
    View PubMed
44. Gross SA, Buchner AM, Crook JE, Cangemi JR, Picco MF, Wolfsen HC, DeVault KR, Loeb DS, Raimondo M, Woodward TA, Wallace MB. A comparison of high definition-image enhanced colonoscopy and standard white-light colonoscopy for colorectal polyp detection. Endoscopy. 2011 Dec; 43 (12):1045-51 Epub 2011 Oct 04
    View PubMed
45. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
    
46. Buchner AM, Gomez V, Heckman MG, Shahid MW, Achem S, Gill KR, Jamil LH, Kahaleh M, Lo SK, Picco M, Riegert-Johnson D, Raimondo M, Sciemeca D, Wolfsen H, Woodward T, Wallace MB. The learning curve of in vivo probe-based confocal laser endomicroscopy for prediction of colorectal neoplasia. Gastrointest Endosc. 2011 Mar; 73 (3):556-60
    View PubMed
47. Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol. 2009 Nov; 104(11):2754-9. Epub 2009 Jul 07.
    View PubMed
48. Cangemi JR, Picco MF. Intestinal ischemia in the elderly. Gastroenterol Clin North Am. 2009 Sep; 38(3):527-40.
    View PubMed
49. Picco MF, Cangemi JR. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2009 Sep; 38(3):447-62.
    View PubMed
50. Edula RG, Picco MF. An evidence-based review of natalizumab therapy in the management of Crohn's disease. Ther Clin Risk Manag. 2009; 5:935-42
    View PubMed
51. Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ, Crohn's and Colitis Foundation of America Clinical Alliance. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13 (10):1250-5
    View PubMed
52. Picco MF, Krishna M, Cangemi JR, Shelton D. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis. 2006 Jul; 12 (7):537-42
    View PubMed
53. Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J, Task Force on Clinical Phenotyping of the IOIBD. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol. 2005 Jul; 100(7):1547-9.
    View PubMed
54. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003 Sep; 9(5):281-9.
    View PubMed
55. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol. 2003 Feb; 98 (2):363-8
    View PubMed
56. Scolapio JS, Picco MF, Tarrosa VB. Enteral versus parenteral nutrition: the patient's preference. JPEN J Parenter Enteral Nutr. 2002 Jul-Aug; 26: (4)248-50.
    View PubMed
57. Lukens FJ, Loeb DS, Machicao VI, Achem SR, Picco MF. Colonoscopy in octogenarians: a prospective outpatient study. Am J Gastroenterol. 2002 Jul; 97 (7):1722-5
    View PubMed
58. Picco MF. Crohn's disease: rational management. Consultant. 2002 Feb; 42(2):185-8, 191-4, 197.
    
59. Picco MF. Crohn Disease: A rational approach to management. Drug Benefit Trends. 2002; 14(Suppl. A):25-33.
    
60. Picco MF, Goodman S, Reed J, Bayless TM. Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med. 2001 Jun 19; 134 (12):1124-9
    View PubMed
61. Picco MF. Ulcerative colitis: a rational approach to management. Consultant. 2001; 41(4):541-548.